8 min read
Monthly FDA Guidance and Regulatory News Review - August 2026
This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...
Advancing Medical Writing and Regulatory Submissions in an Increasingly Complex Environment
November 2026 | Exhibit Hall, Table # 13
Veristat is pleased to participate in the 2026 AMWA Medical Writing & Communication Conference, bringing together medical writing, regulatory, and communications professionals to discuss emerging challenges, evolving technologies, and best practices across the industry.
As regulatory applications become more complex and AI reshapes medical writing and editing, organizations need the right expertise, processes, and strategies to deliver high-quality, submission-ready documentation. Veristat brings deep experience in regulatory science, medical writing, and global submissions to help sponsors navigate these demands and advance development programs toward approval.
Join Our Expert-Led Sessions
Veristat experts will share their perspectives in three conference sessions:
As Regulatory Applications Become More Complex, How Do We Still Deliver Successfully?
November 5 | 9:30–10:30 AM
Brenda Taylor, Director, Global Submissions
Mark Bowlby, Senior Director, Global Submissions
Steve Sibley, VP, Global Submissions
View Session
The AI-Augmented Medical Editor: A 2027 Job Description
November 6 | 10:45–11:45 AM
Featuring Demetrius Carter, Life Sciences Executive, Veristat, alongside industry panelists.
View Session
From Author to Architect: Leading and Operating a High-Impact Medical Writing Function
November 6 | 3:00–4:00 PM
Heather Graham, VP, Regulatory Science and Medical Affairs
View Session
Meet With Us
Visit Veristat at Table #13 in the exhibit hall to discuss your medical writing, regulatory strategy, and global submission needs. Our team looks forward to sharing how integrated expertise can help strengthen submission readiness and advance your development goals.
Schedule a Meeting in Advance
Complete the form on this page to reserve time with our team. We welcome the opportunity to learn about your upcoming programs and explore how Veristat can support your development strategy.
Our Expertise
Whether you're launching a first-in-human study or navigating complex regulatory pathways, Veristat delivers integrated expertise and personalized support across the development lifecycle:
- Full-Service Clinical Development Solutions
- Global Regulatory Strategy & Submissions
- Clinical Operations Excellence
Schedule A Meeting
Meet with us at AMWA 2026 by filling out the form below.
Event Topics:
8 min read
Monthly FDA Guidance and Regulatory News Review - July 2026
Aug 14, 2026 Veristat Blog
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...